Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has reported a change in substantial shareholding, with First Sentier Investors and its associated entities adjusting their voting power in the company. The notice highlights changes in relevant interests and voting securities, including shares held by Mitsubishi UFJ Financial Group. These adjustments in shareholdings and voting rights are crucial for investors tracking ownership and control within the company.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
